New NIST reference material for peptide analysis

May 25, 2007

The National Institute of Standards and Technology (NIST) has issued its first-ever reference material designed to improve the performance and reliability of experiments to measure the masses and concentrations of peptides in biomolecular samples. The new reference material is expected to be an important tool in the analysis of proteins, both for disease diagnosis and drug discovery.

Proteomics—the study of proteins and the roles they play in biology—is one of the most fertile fields of modern medical research. Proteins typically are very large molecules, built of hundreds or thousands of amino acids, but they can be divided into smaller units, chains of about 50 or fewer amino acids. These are peptides. The usual way to analyze proteins is to chop them into their constituent peptides (generally with enzymes that cut through them at specific sites), sort the various peptides out using a chemical separation technique like high performance liquid chromatography (HPLC), and then determine the mass of each peptide using mass spectroscopy.

One big uncertainty in this process is that the peptide fragments differ in size, electrical charge and physical properties (such as the speed in which they separate under HPLC.) Chemists are accustomed to using well-known reference samples as chemical rulers to calibrate their analysis instrumentation, but until now there have been no such reference samples of peptides.

The need for this peptide reference material has been long recognized by the Association of Biomolecular Resource Facilities (ABRF), a non-profit standards organization created by representatives from industry firms, universities and government agencies. In collaboration with NIST, the ABRF created a Peptide Standards Project Committee to design and characterize three synthetic peptides to serve as the basis for a NIST peptide reference material. NIST RM 8327, "Peptide Reference Material for Molecular Mass and Purity Measurements," consists of three peptides from 11, 14 and 26 amino acid residues in length, with net charges of -3, -1 and +3. These three synthetic peptides were designed to provide long-term stability (do not contain methionine, cysteine and tryptophan), a range of purities, a range of molecular masses, protease cleavage sites, and contain tyrosine to enable concentration analysis by UV spectroscopy.

Source: National Institute of Standards and Technology (NIST)

Explore further: Encouraging signs for bee biodiversity

add to favorites email to friend print save as pdf

Related Stories

Proteome atlas for the tuberculosis pathogen

May 15, 2013

Researchers from ETH Zurich have mapped the coordinates for all the proteins of the tuberculosis pathogen Mycobacterium tuberculosis. Thanks to this "atlas", scientists are now able to easily find and accurately measure every ...

Biotech developments signal new breakthrough

Nov 20, 2012

The study of proteins (which are found throughout every cell and tissue in the body) is of specific interest to scientists, as they are an integral part of most biological processes. Proteins are composed ...

Recommended for you

Encouraging signs for bee biodiversity

1 hour ago

Declines in the biodiversity of pollinating insects and wild plants have slowed in recent years, according to a new study. Researchers led by the University of Leeds and the Naturalis Biodiversity Centre in the Netherlands ...

User comments : 0

More news stories

Encouraging signs for bee biodiversity

Declines in the biodiversity of pollinating insects and wild plants have slowed in recent years, according to a new study. Researchers led by the University of Leeds and the Naturalis Biodiversity Centre in the Netherlands ...

If you can remember it, you can remember it wrong

(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...

B vitamins could delay dementia

(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...

New method for producing clean hydrogen

Duke University engineers have developed a novel method for producing clean hydrogen, which could prove essential to weaning society off of fossil fuels and their environmental implications.